Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.TissueGen has announced the availability of its Elute biodegradable drug-loaded fiber products, including pharmaceutical loaded fibers and growth factor loaded fibers.
Subscribe to our email newsletter
The core technology of TissueGen includes patented processes for extrusion of biodegradable drug-loaded fibers at room temperature.
The company’s patented extrusion process at room temperature enables delivery of the widest selection of drugs and biologically-based entities directly to targeted internal sites via its ELUTE biodegradable drug-loaded fibers.
TissueGen CEO Christopher Knowles said that the Elute biodegradable drug-loaded fibers revolutionize the capabilities and performance of implantable medical devices resulting in faster healing, improved patient compliance, and lower negative outcomes at low cost.
"TissueGen loads biodegradable fibers with the widest selection of drugs and therapeutic agents ever possible thanks to our patented room temperature extrusion process resulting in controlled and localized delivery in the body," Knowles added.
Suitable for woven, knitted, or braided formats, Elute biodegradable drug-loaded fibers are used in implantable medical devices where the ability to deliver drugs may add a significant value.
Medical applications include without limitation custom drug delivery, cardiology, dermal wound healing, peripheral nerve regeneration, sutures, vascular stents and grafts, orthopedics, and general surgery.